UBS Maintains Buy on CareTrust REIT, Lowers Price Target to $44
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
UBS analyst Michael Goldsmith maintains CareTrust REIT (NYSE:CTRE) with a Buy and lowers the price target from $48 to $44.
UBS analyst Michael Goldsmith maintains CareTrust REIT (NYSE:CTRE) with a Buy and lowers the price target from $48 to $44.